Traetow W D, Fabri P J, Carey L C
Arch Surg. 1980 Apr;115(4):447-51. doi: 10.1001/archsurg.1980.01380040073013.
During the last three decades, 2,4117 splenectomies have been performed at The Ohio State University Hospital. Indications for splenectomy include hypersplenism, incidental to other abdominal procedures, trauma, Hodgkin's staging, and other splenic disease. Hodgkin's staging has become the most frequent indication for splenectomy during the past five years, whereas splenectomy for hypersplenism has decreased. Thrombocytosis (platelet counts greater than 400,000/cu mm) was observed in 47% of all patients. Ninety-three percent of all thromboembolic complications occurred in this group. The overall morbidity of 39% has been decreased to 15% during the last five years. In-hospital mortality has decreased from 9.5% to 6%. Incidental splenectomy, even for benign disease, continues to be associated with complications and death.
在过去三十年里,俄亥俄州立大学医院共进行了24117例脾切除术。脾切除的适应证包括脾功能亢进、作为其他腹部手术的附带操作、创伤、霍奇金淋巴瘤分期以及其他脾脏疾病。在过去五年中,霍奇金淋巴瘤分期已成为脾切除最常见的适应证,而因脾功能亢进进行的脾切除术则有所减少。在所有患者中,47%观察到血小板增多症(血小板计数大于40万/立方毫米)。所有血栓栓塞并发症的93%发生在该组患者中。总体发病率在过去五年中从39%降至15%。住院死亡率从9.5%降至6%。即使是因良性疾病进行的附带脾切除术,仍会伴有并发症和死亡。